Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |